Download PDF
Semin Neurol 2019; 39(04): 482-494
DOI: 10.1055/s-0039-1687915
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Infectious Etiologies of Stroke

Julie G. Shulman
1   Boston University School of Medicine, Boston University, Boston, Massachusetts
2   Department of Neurology, Boston Medical Center, Boston, Massachusetts
,
Anna M. Cervantes-Arslanian
1   Boston University School of Medicine, Boston University, Boston, Massachusetts
2   Department of Neurology, Boston Medical Center, Boston, Massachusetts
3   Department of Neurosurgery, Boston Medical Center, Boston, Massachusetts
4   Department of Medicine, Boston Medical Center, Boston, Massachusetts
› Author Affiliations
Further Information

Publication History

Publication Date:
18 September 2019 (online)

    Permissions and Reprints

Abstract

Central nervous system (CNS) infections are a frequently underappreciated potential etiology of cerebrovascular disease. Highlighted in this review are a selection of infectious agents that lead to cerebrovascular complications through various mechanisms including multifocal vasculopathy, focal infiltrative vasculitis and vasospasm, and direct vessel wall invasion and thrombus formation. Diagnosis of stroke due to underlying CNS infection requires a high index of clinical suspicion and careful consideration of neuroimaging, serum, and cerebrospinal fluid studies in addition to a detailed history and neurologic examination. Prompt and targeted treatment is essential in these conditions, which frequently herald a poor prognosis. Specifically, cerebrovascular complications associated with varicella zoster virus, syphilis, tuberculosis, aspergillosis, and acute bacterial meningitis are addressed here in detail.

Keywords

stroke - infection - vasculitis - vasculopathy
 

  • References

  • 1 Misra UK, Kalita J, Maurya PK. Stroke in tuberculous meningitis. J Neurol Sci 2011; 303 (1-2): 22-30
    CrossrefPubMedGoogle Scholar
  • 2 Hurst RW, Judkins A, Bolger W, Chu A, Loevner LA. Mycotic aneurysm and cerebral infarction resulting from fungal sinusitis: imaging and pathologic correlation. AJNR Am J Neuroradiol 2001; 22 (05) 858-863
    PubMedGoogle Scholar
  • 3 Chow FC, Marra CM, Cho TA. Cerebrovascular disease in central nervous system infections. Semin Neurol 2011; 31 (03) 286-306
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Grahn A, Studahl M. Varicella-zoster virus infections of the central nervous system – prognosis, diagnostics and treatment. J Infect 2015; 71 (03) 281-293
    CrossrefPubMedGoogle Scholar
  • 5 Reshef E, Greenberg SB, Jankovic J. Herpes zoster ophthalmicus followed by contralateral hemiparesis: report of two cases and review of literature. J Neurol Neurosurg Psychiatry 1985; 48 (02) 122-127
    CrossrefPubMedGoogle Scholar
  • 6 Zhang Y, Luo G, Huang Y, Yu Q, Wang L, Li K. Risk of stroke/transient ischemic attack or myocardial infarction with herpes zoster: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis 2017; 26 (08) 1807-1816
    CrossrefPubMedGoogle Scholar
  • 7 Erskine N, Tran H, Levin L. , et al. A systematic review and meta-analysis on herpes zoster and the risk of cardiac and cerebrovascular events. PLoS One 2017; 12 (07) e0181565
    CrossrefPubMedGoogle Scholar
  • 8 Gray F, Lescs MC, Keohane C. , et al. Early brain changes in HIV infection: neuropathological study of 11 HIV seropositive, non-AIDS cases. J Neuropathol Exp Neurol 1992; 51 (02) 177-185
    CrossrefPubMedGoogle Scholar
  • 9 Petito CK, Cho ES, Lemann W, Navia BA, Price RW. Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. J Neuropathol Exp Neurol 1986; 45 (06) 635-646
    CrossrefPubMedGoogle Scholar
  • 10 Nagel MA, Cohrs RJ, Mahalingam R. , et al. The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology 2008; 70 (11) 853-860
    CrossrefPubMedGoogle Scholar
  • 11 Gilden D, Cohrs RJ, Mahalingam R, Nagel MA. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol 2009; 8 (08) 731-740
    CrossrefPubMedGoogle Scholar
  • 12 Nagel MA, Bubak AN. Varicella zoster virus vasculopathy. J Infect Dis 2018; 218 (suppl_2): S107-S112
    CrossrefPubMedGoogle Scholar
  • 13 Nagel MA, Forghani B, Mahalingam R. , et al. The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology 2007; 68 (13) 1069-1073
    CrossrefPubMedGoogle Scholar
  • 14 Reiber H, Lange P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem 1991; 37 (07) 1153-1160
    CrossrefPubMedGoogle Scholar
  • 15 Küker W. Imaging of cerebral vasculitis. Int J Stroke 2007; 2 (03) 184-190
    CrossrefPubMedGoogle Scholar
  • 16 Gomes LJ. The role of imaging in the diagnosis of central nervous system vasculitis. Curr Allergy Asthma Rep 2010; 10 (03) 163-170
    CrossrefPubMedGoogle Scholar
  • 17 Cheng-Ching E, Jones S, Hui FK. , et al. High-resolution MRI vessel wall imaging in varicella zoster virus vasculopathy. J Neurol Sci 2015; 351 (1-2): 168-173
    CrossrefPubMedGoogle Scholar
  • 18 MacKenzie RA, Forbes GS, Karnes WE. Angiographic findings in herpes zoster arteritis. Ann Neurol 1981; 10 (05) 458-464
    CrossrefPubMedGoogle Scholar
  • 19 Nagel MA, Traktinskiy I, Azarkh Y. , et al. Varicella zoster virus vasculopathy: analysis of virus-infected arteries. Neurology 2011; 77 (04) 364-370
    CrossrefPubMedGoogle Scholar
  • 20 Langan SM, Minassian C, Smeeth L, Thomas SL. Risk of stroke following herpes zoster: a self-controlled case-series study. Clin Infect Dis 2014; 58 (11) 1497-1503
    CrossrefPubMedGoogle Scholar
  • 21 Minassian C, Thomas SL, Smeeth L, Douglas I, Brauer R, Langan SM. Acute cardiovascular events after herpes zoster: a self-controlled case series analysis in vaccinated and unvaccinated older residents of the United States. PLoS Med 2015; 12 (12) e1001919
    CrossrefPubMedGoogle Scholar
  • 22 WHO. Global Tuberculosis Report [Internet]. 2018 . Available at: https://www.who.int/tb/publications/global_report/en/ . Accessed October 27, 2018
    PubMed
  • 23 Donald PR, Schoeman JF. Tuberculous meningitis. N Engl J Med 2004; 351 (17) 1719-1720
    CrossrefPubMedGoogle Scholar
  • 24 Berenguer J, Moreno S, Laguna F. , et al. Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med 1992; 326 (10) 668-672
    CrossrefPubMedGoogle Scholar
  • 25 Kalita J, Misra UK, Nair PP. Predictors of stroke and its significance in the outcome of tuberculous meningitis. J Stroke Cerebrovasc Dis 2009; 18 (04) 251-258
    CrossrefPubMedGoogle Scholar
  • 26 Caplan LR, Bogousslavsky J. , eds. Uncommon Causes of Stroke. 2nd ed. Cambridge, UK; New York: Cambridge University Press; 2008
    Google Scholar
  • 27 Karandanis D, Shulman JA. Recent survey of infectious meningitis in adults: review of laboratory findings in bacterial, tuberculous, and aseptic meningitis. South Med J 1976; 69 (04) 449-457
    CrossrefPubMedGoogle Scholar
  • 28 Kent SJ, Crowe SM, Yung A, Lucas CR, Mijch AM. Tuberculous meningitis: a 30-year review. Clin Infect Dis 1993; 17 (06) 987-994
    CrossrefPubMedGoogle Scholar
  • 29 Kennedy DH, Fallon RJ. Tuberculous meningitis. JAMA 1979; 241 (03) 264-268
    CrossrefPubMedGoogle Scholar
  • 30 Hsieh F-Y, Chia L-G, Shen W-C. Locations of cerebral infarctions in tuberculous meningitis. Neuroradiology 1992; 34 (03) 197-199
    CrossrefPubMedGoogle Scholar
  • 31 Nair PP, Kalita J, Kumar S, Misra UK. MRI pattern of infarcts in basal ganglia region in patients with tuberculous meningitis. Neuroradiology 2009; 51 (04) 221-225
    CrossrefPubMedGoogle Scholar
  • 32 Misra UK, Kalita J, Nair PP. Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial. J Neurol Sci 2010; 293 (1-2): 12-17
    CrossrefPubMedGoogle Scholar
  • 33 Lehrer H. The angiographic triad in tuberculous meningitis. A radiographic and clinicopathologic correlation. Radiology 1966; 87 (05) 829-835
    CrossrefPubMedGoogle Scholar
  • 34 Mathew NT, Abraham J, Chandy J. Cerebral angiographic features in tuberculous meningitis. Neurology 1970; 20 (10) 1015-1023
    CrossrefPubMedGoogle Scholar
  • 35 Koh S-B, Kim B-J, Park MH, Yu S-W, Park K-W, Lee DH. Clinical and laboratory characteristics of cerebral infarction in tuberculous meningitis: a comparative study. J Clin Neurosci 2007; 14 (11) 1073-1077
    CrossrefPubMedGoogle Scholar
  • 36 Turken O, Kunter E, Sezer M. , et al. Hemostatic changes in active pulmonary tuberculosis. Int J Tuberc Lung Dis 2002; 6 (10) 927-932
    PubMedGoogle Scholar
  • 37 Sheu J-J, Chiou H-Y, Kang J-H, Chen Y-H, Lin H-C. Tuberculosis and the risk of ischemic stroke: a 3-year follow-up study. Stroke 2010; 41 (02) 244-249
    CrossrefPubMedGoogle Scholar
  • 38 Giral P, Kahn J-F, André J-M. , et al. Carotid atherosclerosis is not related to past tuberculosis in hypercholesterolemic patients. Atherosclerosis 2007; 190 (01) 150-155
    CrossrefPubMedGoogle Scholar
  • 39 Thwaites GE, Macmullen-Price J, Tran TH. , et al. Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study. Lancet Neurol 2007; 6 (03) 230-236
    CrossrefPubMedGoogle Scholar
  • 40 Thwaites GE, Nguyen DB, Nguyen HD. , et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004; 351 (17) 1741-1751
    CrossrefPubMedGoogle Scholar
  • 41 WHO. Guidelines for treatment of drug-susceptible tuberculosis and patient care [Internet]. 2017. Available at: https://www.who.int/tb/publications/global_report/en/ . Accessed October 26, 2018
    PubMedGoogle Scholar
  • 42 Murthy JMK. Management of intracranial pressure in tuberculous meningitis. Neurocrit Care 2005; 2 (03) 306-312
    CrossrefPubMedGoogle Scholar
  • 43 Center for Disease Control and Prevention. Sexually Transmitted Diseases Surveillance; 2017 [Internet]. Available at: https://www.cdc.gov/std/stats17/2017-STD-Surveillance-Report_CDC-clearance-9.10.18.pdf . Accessed October 15, 2018
    PubMed
  • 44 Hobbs E, Vera JH, Marks M, Barritt AW, Ridha BH, Lawrence D. Neurosyphilis in patients with HIV. Pract Neurol 2018; 18 (03) 211-218
    CrossrefPubMedGoogle Scholar
  • 45 Gordon SM, Eaton ME, George R. , et al. The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with human immunodeficiency virus infection. N Engl J Med 1994; 331 (22) 1469-1473
    CrossrefPubMedGoogle Scholar
  • 46 Marra CM, Critchlow CW, Hook III EW, Collier AC, Lukehart SA. Cerebrospinal fluid treponemal antibodies in untreated early syphilis. Arch Neurol 1995; 52 (01) 68-72
    CrossrefPubMedGoogle Scholar
  • 47 Halperin JJ. Neuroborreliosis and neurosyphilis. Continuum (Minneap Minn) 2018; 24 (5, Neuroinfectious Disease): 1439-1458
    PubMedGoogle Scholar
  • 48 Lukehart SA, Hook III EW, Baker-Zander SA, Collier AC, Critchlow CW, Handsfield HH. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med 1988; 109 (11) 855-862
    PubMedGoogle Scholar
  • 49 Ghanem KG. Review: neurosyphilis: a historical perspective and review. CNS Neurosci Ther 2010; 16 (05) e157-e168
    CrossrefPubMedGoogle Scholar
  • 50 Timmermans M, Carr J. Neurosyphilis in the modern era. J Neurol Neurosurg Psychiatry 2004; 75 (12) 1727-1730
    CrossrefPubMedGoogle Scholar
  • 51 Holmes MD, Brant-Zawadzki MM, Simon RP. Clinical features of meningovascular syphilis. Neurology 1984; 34 (04) 553-556
    CrossrefPubMedGoogle Scholar
  • 52 Liu L-L, Zheng W-H, Tong M-L. , et al. Ischemic stroke as a primary symptom of neurosyphilis among HIV-negative emergency patients. J Neurol Sci 2012; 317 (1-2): 35-39
    CrossrefPubMedGoogle Scholar
  • 53 Drago F, Merlo G, Ciccarese G. , et al. Changes in neurosyphilis presentation: a survey on 286 patients. Journal of the European Academy of Dermatology and Venereology [Internet]; 2016 . Available at: http://doi.wiley.com/10.1111/jdv.13753 . Accessed October 12, 2018
    PubMed
  • 54 Conde-Sendín MA, Amela-Peris R, Aladro-Benito Y, Maroto AA. Current clinical spectrum of neurosyphilis in immunocompetent patients. Eur Neurol 2004; 52 (01) 29-35
    CrossrefPubMedGoogle Scholar
  • 55 Asdaghi N, Muayqil T, Scozzafava J, Jassal R, Saqqur M, Jeerakathil TJ. The re-emergence in Canada of meningovascular syphilis: 2 patients with headache and stroke. CMAJ 2007; 176 (12) 1699-1700
    CrossrefPubMedGoogle Scholar
  • 56 Merritt HH, Adams RD, Solomon HC. Neurosyphilis. New York: Oxford University Press; 1946
    Google Scholar
  • 57 Tyler KL, Sandberg E, Baum KF. Medical medullary syndrome and meningovascular syphilis: a case report in an HIV-infected man and a review of the literature. Neurology 1994; 44 (12) 2231-2235
    CrossrefPubMedGoogle Scholar
  • 58 Ahbeddou N, El Alaoui Taoussi K, Ibrahimi A. , et al. Stroke and syphilis: a retrospective study of 53 patients. Rev Neurol (Paris) 2018; 174 (05) 313-318
    CrossrefPubMedGoogle Scholar
  • 59 Terry P, Glancy G, Graham A. Meningovascular syphilis of the spinal cord presenting with incomplete Brown-Sequard syndrome: case report. Genitourin Med 1989; 65: 189-191
    PubMedGoogle Scholar
  • 60 Adams R, Merritt H. Meningeal and vascular syphilis of the spinal cord. Medicine (Baltimore) 1944; 23: 181-214
    CrossrefPubMedGoogle Scholar
  • 61 Cordato DJ, Djekic S, Taneja SR. , et al. Prevalence of positive syphilis serology and meningovascular neurosyphilis in patients admitted with stroke and TIA from a culturally diverse population (2005-09). J Clin Neurosci 2013; 20 (07) 943-947
    CrossrefPubMedGoogle Scholar
  • 62 Simon RP. Neurosyphilis. Arch Neurol 1985; 42 (06) 606-613
    CrossrefPubMedGoogle Scholar
  • 63 Marra CM, Gary DW, Kuypers J, Jacobson MA. Diagnosis of neurosyphilis in patients infected with human immunodeficiency virus type 1. J Infect Dis 1996; 174 (01) 219-221
    CrossrefPubMedGoogle Scholar
  • 64 Vanhaecke C, Grange P, Benhaddou N. , et al; Neurosyphilis Network; Neurosyphilis network. Clinical and biological characteristics of 40 patients with neurosyphilis and evaluation of treponema pallidum nested polymerase chain reaction in cerebrospinal fluid samples. Clin Infect Dis 2016; 63 (09) 1180-1186
    PubMedGoogle Scholar
  • 65 Marra CM, Maxwell CL, Smith SL. , et al. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 2004; 189 (03) 369-376
    CrossrefPubMedGoogle Scholar
  • 66 Davis LE, Schmitt JW. Clinical significance of cerebrospinal fluid tests for neurosyphilis. Ann Neurol 1989; 25 (01) 50-55
    CrossrefPubMedGoogle Scholar
  • 67 Landi G, Villani F, Anzalone N. Variable angiographic findings in patients with stroke and neurosyphilis. Stroke 1990; 21 (02) 333-338
    CrossrefPubMedGoogle Scholar
  • 68 Vatz KA, Scheibel RL, Keiffer SA, Ansari KA. Neurosyphilis and diffuse cerebral angiopathy: a case report. Neurology 1974; 24 (05) 472-476
    CrossrefPubMedGoogle Scholar
  • 69 Bagatti D, Mazibrada J, Ligarotti GKI, Nazzi V, Franzini A. A singular case of neurosyphilis manifesting through a meningovascular chronic inflammatory process in association with the occurrence of two aneurysms involving the distal A2 segment of both anterior cerebral arteries: a case report and review of the literature. World Neurosurg 2016; 87: 662.e13-662.e18
    CrossrefPubMedGoogle Scholar
  • 70 Visoná de Figueiredo NS, Moraes Angst DB, Mendes LS, Machado MF, Guimarães Rocha MS, Dozzi Brucki SM. Basilar artery aneurysm in a woman with syphilis. JAMA Neurol 2015; 72 (06) 720-721
    CrossrefPubMedGoogle Scholar
  • 71 Ellison D, Love S. Chronic bacterial infections and neurosarcoidosis. In: Neuropathology. London: Mosby; 2000: 16.5-16.6
    Google Scholar
  • 72 Harriman D. Bacterial infections of the central nervous system. In: Greenfield's Neuropathology. Chicago: Yearbook Medical Publishers; 1976: 238-268
    Google Scholar
  • 73 Behrous R, Malek AR, Chichkova RI. Meningo-vascular syphilis: revisiting an old adversary. Pract Neurol 2011; 32-37
    PubMedGoogle Scholar
  • 74 Kelley RE, Minagar A, Kelley BJ, Brunson R. Transcranial Doppler monitoring of response to therapy for meningovascular syphilis. J Neuroimaging 2003; 13 (01) 85-87
    CrossrefPubMedGoogle Scholar
  • 75 Davis L, Graham G. Neurosyphilis and Stroke. In: Caplan LR. ed. Uncommon Causes of Stroke. New York, NY: Cambridge University Press; 2008: 35-39
    Google Scholar
  • 76 Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26 (04) 781-803 , quiz 804–805
    CrossrefPubMedGoogle Scholar
  • 77 Fugate JE, Lyons JL, Thakur KT, Smith BR, Hedley-Whyte ET, Mateen FJ. Infectious causes of stroke. Lancet Infect Dis 2014; 14 (09) 869-880
    CrossrefPubMedGoogle Scholar
  • 78 Kleinschmidt-DeMasters BK. Central nervous system aspergillosis: a 20-year retrospective series. Hum Pathol 2002; 33 (01) 116-124
    CrossrefPubMedGoogle Scholar
  • 79 Góralska K, Blaszkowska J, Dzikowiec M. Neuroinfections caused by fungi. Infection 2018; 46 (04) 443-459
    CrossrefPubMedGoogle Scholar
  • 80 Ho CL, Deruytter MJ. CNS aspergillosis with mycotic aneurysm, cerebral granuloma and infarction. Acta Neurochirurgica [Internet]; 2004 ;146(8). Available at: http://link.springer.com/10.1007/s00701-004-0292-6 . Accessed June 18, 2018
    PubMedGoogle Scholar
  • 81 Patterson TF, Thompson III GR, Denning DW. , et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 2016; 63 (04) e1-e60
    CrossrefPubMedGoogle Scholar
  • 82 Arvanitis M, Anagnostou T, Mylonakis E. Galactomannan and polymerase chain reaction-based screening for invasive aspergillosis among high-risk hematology patients: a diagnostic meta-analysis. Clin Infect Dis 2015; 61 (08) 1263-1272
    CrossrefPubMedGoogle Scholar
  • 83 Lamoth F. Galactomannan and 1,3-β-d-glucan testing for the diagnosis of invasive aspergillosis. J Fungi (Basel) 2016; 2 (03) 22
    PubMedGoogle Scholar
  • 84 Imbert S, Brossas J-Y, Palous M, Joly I, Meyer I, Fekkar A. Performance of Aspergillus PCR in cerebrospinal fluid for the diagnosis of cerebral aspergillosis. Clin Microbiol Infect 2017; 23 (11) 889.e1-889.e4
    CrossrefPubMedGoogle Scholar
  • 85 Chong GM, Maertens JA, Lagrou K, Driessen GJ, Cornelissen JJ, Rijnders BJA. Diagnostic performance of galactomannan antigen testing in cerebrospinal fluid. J Clin Microbiol 2016; 54 (02) 428-431
    CrossrefPubMedGoogle Scholar
  • 86 Ashdown BC, Tien RD, Felsberg GJ. Aspergillosis of the brain and paranasal sinuses in immunocompromised patients: CT and MR imaging findings. AJR Am J Roentgenol 1994; 162 (01) 155-159
    CrossrefPubMedGoogle Scholar
  • 87 Scheld WM, Koedel U, Nathan B, Pfister H-W. Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. J Infect Dis 2002; 186 (Suppl. 02) S225-S233
    CrossrefPubMedGoogle Scholar
  • 88 Thigpen MC, Whitney CG, Messonnier NE. , et al; Emerging Infections Programs Network. Bacterial meningitis in the United States, 1998-2007. N Engl J Med 2011; 364 (21) 2016-2025
    CrossrefPubMedGoogle Scholar
  • 89 Durand ML, Calderwood SB, Weber DJ. , et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993; 328 (01) 21-28
    CrossrefPubMedGoogle Scholar
  • 90 Kastenbauer S, Pfister H-W. Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain 2003; 126 (Pt 5): 1015-1025
    CrossrefPubMedGoogle Scholar
  • 91 Schut ES, Lucas MJ, Brouwer MC, Vergouwen MDI, van der Ende A, van de Beek D. Cerebral infarction in adults with bacterial meningitis. Neurocrit Care 2012; 16 (03) 421-427
    CrossrefPubMedGoogle Scholar
  • 92 Pfister H-W, Borasio GD, Dirnagl U, Bauer M, Einhäupl KM. Cerebrovascular complications of bacterial meningitis in adults. Neurology 1992; 42 (08) 1497-1504
    CrossrefPubMedGoogle Scholar
  • 93 de Gans J, van de Beek D. ; European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002; 347 (20) 1549-1556
    CrossrefPubMedGoogle Scholar
  • 94 van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004; 351 (18) 1849-1859
    CrossrefPubMedGoogle Scholar
  • 95 Klein M, Koedel U, Pfefferkorn T, Zeller G, Woehrl B, Pfister H-W. Arterial cerebrovascular complications in 94 adults with acute bacterial meningitis. Crit Care 2011; 15 (06) R281
    CrossrefPubMedGoogle Scholar
  • 96 Katchanov J, Siebert E, Klingebiel R, Endres M. Infectious vasculopathy of intracranial large- and medium-sized vessels in neurological intensive care unit: a clinico-radiological study. Neurocrit Care 2010; 12 (03) 369-374
    CrossrefPubMedGoogle Scholar
  • 97 Weisfelt M, de Gans J, van der Poll T, van de Beek D. Pneumococcal meningitis in adults: new approaches to management and prevention. Lancet Neurol 2006; 5 (04) 332-342
    CrossrefPubMedGoogle Scholar
  • 98 Weststrate W, Hijdra A, de Gans J. Brain infarcts in adults with bacterial meningitis. Lancet 1996; 347 (8998): 399
    PubMedGoogle Scholar
  • 99 van de Beek D, Patel R, Wijdicks EFM. Meningococcal meningitis with brainstem infarction. Arch Neurol 2007; 64 (09) 1350-1351
    CrossrefPubMedGoogle Scholar
  • 100 Czartoski T, Hallam D, Lacy JM, Chun MR, Becker K. Postinfectious vasculopathy with evolution to moyamoya syndrome. J Neurol Neurosurg Psychiatry 2005; 76 (02) 256-259
    CrossrefPubMedGoogle Scholar
  • 101 Brouwer MC, McIntyre P, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2015; (09) CD004405
    PubMedGoogle Scholar
  • 102 Pugin D, Copin J-C, Goodyear M-C, Landis T, Gasche Y. Persisting vasculitis after pneumococcal meningitis. Neurocrit Care 2006; 4 (03) 237-240
    CrossrefPubMedGoogle Scholar